110 related articles for article (PubMed ID: 7199476)
1. Serum sialic acid concentrations in malignant melanoma.
Ryan AH; Fennelly JJ
Eur J Cancer Clin Oncol; 1981 Jul; 17(7):843-4. PubMed ID: 7199476
[No Abstract] [Full Text] [Related]
2. Serum sialic acid elevations in malignant melanoma patients.
Silver HK; Rangel DM; Morton DL
Cancer; 1978 Apr; 41(4):1497-9. PubMed ID: 639006
[TBL] [Abstract][Full Text] [Related]
3. Sialyltransferase levels and sialic acid concentrations in sera of patients with malignant melanomas.
Herrmann WP; Gielen W
Arch Dermatol Res; 1979 Jul; 265(3):321-9. PubMed ID: 475455
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significant of sialic acid concentrations in the serum of melanoma patients].
Hermann WP; Gielen W
Hautarzt; 1980 Apr; 31(4):184-7. PubMed ID: 7399910
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of putative tumor markers for malignant melanoma.
Reintgen DS; Cruse CW; Wells KE; Saba HI; Fabri PJ
Ann Plast Surg; 1992 Jan; 28(1):55-9. PubMed ID: 1642407
[TBL] [Abstract][Full Text] [Related]
6. [Tumor markers in melanoma].
Morsches B; Prellwitz W; Benes P; Schramm P; Trumpfheller R; Korting GW
Dermatol Monatsschr; 1984; 170(6):380-90. PubMed ID: 6205909
[No Abstract] [Full Text] [Related]
7. [Serum sialic acid bound to lipoproteins. Its contribution to the diagnosis and follow-up of melanoma].
Sánchez Conejo-Mir J; Sotillo Gago I; Camacho F; Iglesias Huertas R
Med Cutan Ibero Lat Am; 1990; 18(4):219-23. PubMed ID: 2077306
[TBL] [Abstract][Full Text] [Related]
8. Serum sialic acid and sialyltransferase as monitors of tumor burden in malignant melanoma patients.
Silver HK; Karim KA; Archibald EL; Salinas FA
Cancer Res; 1979 Dec; 39(12):5036-42. PubMed ID: 498130
[No Abstract] [Full Text] [Related]
9. Evaluation of serum sialic acid fractions as markers for malignant melanoma.
Vedralová E; Borovanský J
Cancer Lett; 1994 Apr; 78(1-3):171-5. PubMed ID: 8180959
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of malignant melanoma.
Matous B; Cigánek EF; Budĕsínská A; Duchon J
Neoplasma; 1987; 34(1):77-84. PubMed ID: 3104808
[TBL] [Abstract][Full Text] [Related]
11. Prediction of malignant melanoma recurrence by serum N-acetylneuraminic acid.
Silver HK; Murray RN; Worth AJ; Salinas FA; Spinelli JJ
Int J Cancer; 1983 Jan; 31(1):39-43. PubMed ID: 6832847
[TBL] [Abstract][Full Text] [Related]
12. Serum sialic acid in malignant melanoma patients: an ROC curve analysis.
Ros-Bullón MR; Sánchez-Pedreño P; Martínez-Liarte JH
Anticancer Res; 1999; 19(4C):3619-22. PubMed ID: 10629661
[TBL] [Abstract][Full Text] [Related]
13. Relationship of total serum sialic acid to sialylglycoprotein acute-phase reactants in malignant melanoma.
Silver HK; Karim KA; Salinas FA
Br J Cancer; 1980 May; 41(5):745-50. PubMed ID: 6158966
[TBL] [Abstract][Full Text] [Related]
14. Metastatic uveal melanoma. Hepatic cell-surface enzymes, isoenzymes, and serum sialic acid levels in early metastatic disease.
Donoso LA; Nagy RM; Brockman RJ; Augsburger JJ; Shields JA; Berd D; Mastrangelo MJ
Arch Ophthalmol; 1983 May; 101(5):791-4. PubMed ID: 6847471
[TBL] [Abstract][Full Text] [Related]
15. [Circulating lipid-bound sialic acid levels in patients with malignant tumors].
Bassalyk LS; Novikov AM; Sokolova VD; Sorokin EN
Vopr Med Khim; 1984; 30(3):124-7. PubMed ID: 6474937
[TBL] [Abstract][Full Text] [Related]
16. Nuclear DNA, serum sialic acid and measured depth in malignant melanoma for predicting disease recurrence and survival.
Silver HK; Karim KA; Le Riche J; de Jong G; Spinelli J; Worth A; McLean DI; Gallagher R
Int J Cancer; 1989 Jul; 44(1):31-4. PubMed ID: 2744894
[TBL] [Abstract][Full Text] [Related]
17. An original method for submacroscopic metastases visualization in cases of cancer minimal residual disease.
Le Pape A; Barot-Ciorbaru R; Musset M; Baulieu JL; Jubault C; Lemarié E; Pourcelot L; Besnard JC; Nicolau C; Mathé G
Biomed Pharmacother; 1986; 40(10):392-8. PubMed ID: 3580508
[TBL] [Abstract][Full Text] [Related]
18. [Lipid-bound serum sialic acids in the complex diagnosis of recurrences of cancer of the ovary].
Bassalyk LS; Novikov AM; Makhova EE; Kozachenko VP
Vestn Akad Med Nauk SSSR; 1985; (9):67-70. PubMed ID: 4060879
[No Abstract] [Full Text] [Related]
19. [Diagnostic significance of serum hemopexin in patients with malignant melanoma].
Popović S; Roguljić A; Nola P; Maricić Z
Lijec Vjesn; 1975; 97(4):241-4. PubMed ID: 1177660
[No Abstract] [Full Text] [Related]
20. Possible case for false-positive reaction in serum 5-S-cysteinyldopa levels in a patient with malignant melanoma by ingestion of Agaricus blazei Murrill extract.
Konishi H; Yamanaka K; Mizutani H
J Dermatol; 2010 Aug; 37(8):773-5. PubMed ID: 20649730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
